In the current study, IP-10 was differentially expressed in patients with NPC displaying different organ metastases, with high levels in bone, liver, and multiple organs leading to poor prognosis and low levels in lung metastasis cases with longer survival. Here, CXCL10 is linked to nasopharyngeal carcinoma.